Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Organic Letters
Letter
Bawa, S. Eur. J. Med. Chem. 2015, 97, 871. (i) Suresh, K.; Sandhya, B.;
Himanshu, G. Mini-Rev. Med. Chem. 2009, 9, 1648. (j) Parker, W. B.
Chem. Rev. 2009, 109, 2880.
(2) (a) Wong, K.-T.; Hung, T. S.; Lin, Y.; Wu, C.-C.; Lee, G.-H.; Peng,
S.-M.; Chou, C. H.; Su, Y. O. Org. Lett. 2002, 4, 513. (b) Itami, K.;
Yamazaki, D.; Yoshida, J.-i. J. Am. Chem. Soc. 2004, 126, 15396.
(c) Rouffet, M.; de Oliveira, C. A. F.; Udi, Y.; Agrawal, A.; Sagi, I.;
McCammon, J. A.; Cohen, S. M. J. Am. Chem. Soc. 2010, 132, 8232.
(d) Bhalla, V.; Vij, V.; Kumar, M.; Sharma, P. R.; Kaur, T. Org. Lett. 2012,
14, 1012.
which can then be oxidized under the reaction conditions to
afford quinoline. For the formation of Troger’s base,
intermediate 18 can be trapped by aniline to afford the aminal
24, which can then lead to another iminium 26 after reacting with
the DMSO derived sulfenium ion. Intramolecular cyclization of
26 would provide the six-membered intermediate 27, which will
undergo a similar series of steps to eventually furnish Troger’s
base.10 In the case of pyrimidines, condensation of formamide
with acetophenone would provide imine 28, which can react
further with formamide to afford the diene intermediate 29.11
Activation of 29 by K2S2O8 in a manner analogous to that of
DMSO activation will lead to 30, which can undergo a 6π
electrocyclization to result in the ring formation. Subsequent
elimination would lead to the pyrimidine product.
In summary, we have described two oxidative annulation
reactions involving DMSO and formamide as routes toward
quinolines and pyrimidines, respectively. The reactions
developed employ readily available precursors, do not involve
precious transition metals, and provide convenient access to
these heterocycles by incorporating atoms from DMSO and
formamide into the ring systems. Our success in engaging aniline
in such an intermolecular setting demonstrates that it is not
necessary to rely on intricately designed precursors to obtain
selectivity in this reaction manifold. The concept of oxidative
activation of DMSO was successfully extended to pyrimidine
synthesis wherein two molecules of formamide were incorpo-
rated in the heterocyclic ring. Application of this method toward
the synthesis of other classes of heterocycles is being pursued in
our laboratories.
(3) (a) Mahfoudh, M.; Abderrahim, R.; Leclerc, E.; Campagne, J.-M.
Eur. J. Org. Chem. 2017, 2017, 2856. (b) Khong, S.; Kwon, O. J. Org.
Chem. 2012, 77, 8257. (c) Frutos, R. P.; Wei, X.; Patel, N. D.; Tampone,
T. G.; Mulder, J. A.; Busacca, C. A.; Senanayake, C. H. J. Org. Chem.
2013, 78, 5800. (d) Zhou, Y.; Tang, Z.; Song, Q. Adv. Synth. Catal. 2017,
359, 952. (e) Zhan, J.-L.; Wu, M.-W.; Chen, F.; Han, B. J. Org. Chem.
2016, 81, 11994. (f) Vander Mierde, H.; Ledoux, N.; Allaert, B.; Van Der
Voort, P.; Drozdzak, R.; De Vos, D.; Verpoort, F. New J. Chem. 2007, 31,
1572. (g) Pollack, S. R.; Kuethe, J. T. Org. Lett. 2016, 18, 6388.
(h) Chanda, T.; Verma, R. K.; Singh, M. S. Chem. - Asian J. 2012, 7, 778.
(i) Bharate, J. B.; Vishwakarma, R. A.; Bharate, S. B. RSC Adv. 2015, 5,
42020. (j) Yan, R.; Liu, X.; Pan, C.; Zhou, X.; Li, X.; Kang, X.; Huang, G.
Org. Lett. 2013, 15, 4876. (k) Matsubara, Y.; Hirakawa, S.; Yamaguchi,
Y.; Yoshida, Z.-i. Angew. Chem., Int. Ed. 2011, 50, 7670. (l) Wang, S.; Lu,
H.; Li, J.; Zou, D.; Wu, Y.; Wu, Y. Tetrahedron Lett. 2017, 58, 2723.
(4) (a) Thirupathi, N.; Puri, S.; Reddy, T. J.; Sridhar, B.; Reddy, M. S.
Adv. Synth. Catal. 2016, 358, 303. (b) Gadakh, S. K.; Dey, S.; Sudalai, A.
Org. Biomol. Chem. 2016, 14, 2969. (c) Neuhaus, J. D.; Morrow, S. M.;
Brunavs, M.; Willis, M. C. Org. Lett. 2016, 18, 1562. (d) O’Dell, D. K.;
Nicholas, K. M. J. Org. Chem. 2003, 68, 6427. (e) Sangu, K.; Fuchibe, K.;
Akiyama, T. Org. Lett. 2004, 6, 353. (f) Matsubara, Y.; Hirakawa, S.;
Yamaguchi, Y.; Yoshida, Z.-i. Angew. Chem. 2011, 123, 7812. (g) Zhang,
L.; Zheng, L.; Guo, B.; Hua, R. J. Org. Chem. 2014, 79, 11541.
(5) (a) Liu, Y.; Zhan, X.; Ji, P.; Xu, J.; Liu, Q.; Luo, W.; Chen, T.; Guo,
C. Chem. Commun. 2017, 53, 5346. (b) Mahajan, P. S.; Tanpure, S. D.;
More, N. A.; Gajbhiye, J. M.; Mhaske, S. B. RSC Adv. 2015, 5, 101641.
(c) Sun, K.; Wang, X.; Jiang, Y.; Lv, Y.; Zhang, L.; Xiao, B.; Li, D.; Zhu,
Z.; Liu, L. Chem. - Asian J. 2015, 10, 536. (d) Sun, K.; Lv, Y.; Zhu, Z.;
Zhang, L.; Wu, H.; Liu, L.; Jiang, Y.; Xiao, B.; Wang, X. RSC Adv. 2015, 5,
3094.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Full experimental procedures, analytical data, and NMR
spectra of all novel compounds (PDF)
(6) (a) Liu, Y.-F.; Ji, P.-Y.; Xu, J.-W.; Hu, Y.-Q.; Liu, Q.; Luo, W.-P.;
Guo, C.-C. J. Org. Chem. 2017, 82, 7159. (b) Jones-Mensah, E.; Karki,
M.; Magolan, J. Synthesis 2016, 48, 1421.
(7) (a) Xie, C.; Zhang, Z.; Li, D.; Gong, J.; Han, X.; Liu, X.; Ma, C. J.
Org. Chem. 2017, 82, 3491. (b) Lv, Y.; Li, Y.; Xiong, T.; Pu, W.; Zhang,
H.; Sun, K.; Liu, Q.; Zhang, Q. Chem. Commun. 2013, 49, 6439.
(c) Yuan, J.; Yu, J.-T.; Jiang, Y.; Cheng, J. Org. Biomol. Chem. 2017, 15,
1334.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Anand Singh: 0000-0001-9703-6306
Notes
(8) Wakade, S. B.; Tiwari, D. K.; Ganesh, P. S. K. P.; Phanindrudu, M.;
Likhar, P. R.; Tiwari, D. K. Org. Lett. 2017, 19, 4948.
(9) (a) Wu, X.-F.; Natte, K. Adv. Synth. Catal. 2016, 358, 336. (b) Jiang,
X.; Wang, C.; Wei, Y.; Xue, D.; Liu, Z.; Xiao, J. Chem. - Eur. J. 2014, 20,
58.
(10) (a) Didier, D.; Tylleman, B.; Lambert, N.; Vande Velde, C. M. L.;
Blockhuys, F.; Collas, A.; Sergeyev, S. Tetrahedron 2008, 64, 6252.
(b) Li, Z.; Xu, X.; Peng, Y.; Jiang, Z.; Ding, C.; Qian, X. Synthesis 2005,
2005, 1228.
(11) (a) Tyagarajan, S.; Chakravarty, P. K. Tetrahedron Lett. 2005, 46,
7889. (b) Ingebrigtsen, T.; Helland, I.; Lejon, T. Heterocycles 2005, 65,
2593.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
A.S. acknowledges financial support from SERB (SERB/CHM/
2015202) and BRNS (BRNS/CHM/2014118). S.D.J. thanks
UGC, New Delhi for a research fellowship.
REFERENCES
■
(1) (a) Ding, S.; Gray, N. S.; Wu, X.; Ding, Q.; Schultz, P. G. J. Am.
Chem. Soc. 2002, 124, 1594. (b) Capdeville, R. B. E.; Zimmerman, J.;
Matter, A. Nat. Rev. Drug Discovery 2002, 1, 493. (c) Zhang, J.-Q.; Luo,
Y.-J.; Xiong, Y.-S.; Yu, Y.; Tu, Z.-C.; Long, Z.-J.; Lai, X.-J.; Chen, H.-X.;
Luo, Y.; Weng, J.; Lu, G. J. Med. Chem. 2016, 59, 7268. (d) Solomon, V.
R.; Lee, H. Curr. Med. Chem. 2011, 18, 1488. (e) Singh, S.; Kaur, G.;
Mangla, V.; Gupta, M. K. J. Enzyme Inhib. Med. Chem. 2015, 30, 492.
(f) Michael, J. P. Nat. Prod. Rep. 2001, 18, 543. (g) Andrews, S.; Burgess,
S. J.; Skaalrud, D.; Kelly, J. X.; Peyton, D. H. J. Med. Chem. 2010, 53, 916.
(h) Afzal, O.; Kumar, S.; Haider, M. R.; Ali, M. R.; Kumar, R.; Jaggi, M.;
D
DOI: 10.1021/acs.orglett.7b02838
Org. Lett. XXXX, XXX, XXX−XXX